Dr. Olumide Gbolahan
Claim this profileEmory University Hospital/Winship Cancer Institute
Studies Colorectal Cancer
Studies Liver Cancer
13 reported clinical trials
39 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
Stage I
2Liver Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Olumide Gbolahan is currently running
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
Lenvatinib
for Recurrent Liver Cancer Post-Transplant
This phase II trial evaluates lenvatinib for the treatment of hepatocellular carcinoma (HCC) that has come back (recurrent) after a liver transplant. HCC is a cancer of the liver and is the second leading cause of cancer-related deaths in the world. Liver transplantation is a potentially curative treatment option for HCC, however, up to 20% of patients develop recurrent disease after liver transplantation and prognosis remains poor. Lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Systemic treatments for HCC have not been studied in patients with recurrent HCC after liver transplantation, so there is no established therapy for these patients. This phase II trial evaluates lenvatinib for this purpose.
Recruiting1 award Phase 2
More about Olumide Gbolahan
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Olumide Gbolahan has experience with
- Bevacizumab
- Trastuzumab
- Tucatinib
- Regorafenib
- Oxaliplatin
- Fluorouracil
Breakdown of trials Olumide Gbolahan has run
Colorectal Cancer
Liver Cancer
Bile Duct Cancer
Cancer
Hepatocellular Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Olumide Gbolahan specialize in?
Olumide Gbolahan focuses on Colorectal Cancer and Liver Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Olumide Gbolahan currently recruiting for clinical trials?
Yes, Olumide Gbolahan is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Olumide Gbolahan has studied deeply?
Yes, Olumide Gbolahan has studied treatments such as Bevacizumab, Trastuzumab, Tucatinib.
What is the best way to schedule an appointment with Olumide Gbolahan?
Apply for one of the trials that Olumide Gbolahan is conducting.
What is the office address of Olumide Gbolahan?
The office of Olumide Gbolahan is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.